Nilo Therapeutics
PrivateLast Round
Series A
Oct 8, 2025
Total Funding Raised
$101M
Momentum Score
50 /100
Company Overview
Nilo Therapeutics is a biotechnology company that develops a class of medicines that harness neural circuits to restore immune homeostasis in disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nilo Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Nilo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 8, 2025 |
Key People
Founding team and executive leadership
Nilo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series A |
| DCVC Bio | Series A |
| Gates Family Foundation | Series A |
| Lux Capital | Series A |
| Gates Foundation | Series A |
| Bill & Melinda Gates Foundation | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2025
$101M Series A round completed.
- Oct 8, 2025
Kim Seth, Ph.D. appointed as Chief Executive Officer and Board director.
Nilo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nilo Therapeutics's valuation, stock price, and market status.
